Product Information
CAPECITABINE 150 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.3615 per EA under NDC 68001048706. Its NADAC has been published 115 times since May 22, 2024.
FDA first approved this application on Apr 23, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001048706
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
6/17/2026
Active Ingredients
CAPECITABINEApproval Type
Generic (ANDA)
FDA Application
ANDA202593FDA Approved
4/23/2015
TE Code
AB
On Market Since
2/22/2021
Pharmacological Classes
Price Statistics
The NADAC for CAPECITABINE 150 MG TABLET has been published 115 times since May 22, 2024, and over the history we have for it it has declined 33.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3615 per EA |
|---|---|
| All-time high | $0.5392 (Jun 12, 2024) |
| All-time low | $0.2292 (Mar 19, 2025) |
| 52-week high | $0.4038 |
| 52-week low | $0.3615 |
| Median price | $0.3955 |
| Average price | $0.3641 |
| Largest weekly change | -37.1% (Nov 20, 2024) |
| Weeks tracked | 115 |
| Tracking since | May 22, 2024 |
1W
N/A
1M
0.0%
3M
0.0%
6M
-8.6%
1Y
-10.5%
3Y
N/A
5Y
N/A
All
-33.0%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CAPECITABINE 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CAPECITABINE 150 MG TABLET, manufactured by BluePoint Laboratories, is $0.3615 per EA (NDC 68001048706), effective Jul 29, 2026.
How has the price of CAPECITABINE 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for CAPECITABINE 150 MG TABLET has declined 33.0%. It has been tracked across 115 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for CAPECITABINE 150 MG TABLET?
Since May 22, 2024, the NADAC for CAPECITABINE 150 MG TABLET has ranged from a low of $0.2292 (Mar 19, 2025) to a high of $0.5392 (Jun 12, 2024), with a median of $0.3955 per EA.
Are there cheaper alternatives to CAPECITABINE 150 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CAPECITABINE 150 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CAPECITABINE 150 MG TABLET?
CAPECITABINE 150 MG TABLET (NDC 68001048706) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.